Boston Scientific Corp. Stock Falls 4.1%, Underperforms Peers

Dow Jones
09/11

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Boston Scientific Corp. slipped 4.1% to $43.10 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,591.70 and Dow Jones Industrial Average falling 0.6% to 52,064.10.

This was the stock's third consecutive day of losses.

Boston Scientific Corp. closed 60.1% below its 52-week high of $108.07, which the company reached on September 10th.

The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 1.8% to $103.36, Medtronic PLC fell 0.3% to $91.62, and Stryker Corp. fell 1.95% to $270.01.

Trading volume totaled 22.6 million, compared to the 50-day average of 19.9 million.

Data source: Dow Jones Market Data, FactSet

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10